Hashimoto’s encephalopathy presenting with vertigo and muscle weakness in a male pediatric patient

DOI
  • Ueno Hiroe
    Department of Pediatrics, National Hospital Organization, Kumamoto Saisyunsou National Hospital
  • Nishizato Chizuru
    Department of Pediatrics, National Hospital Organization, Kumamoto Saisyunsou National Hospital
  • Shimazu Tomoyuki
    Department of Pediatrics, National Hospital Organization, Kumamoto Saisyunsou National Hospital
  • Watanabe Hiziri
    Department of Pediatrics, Minamata City General Hospital and Medical Center
  • Mizukami Tomoyuki
    Department of Pediatrics, National Hospital Organization, Kumamoto Medical Center
  • Kosuge Hiroshi
    Department of Pediatrics, Kumamoto University Hospital
  • Ozasa Shiro
    Department of Pediatrics, Kumamoto University Hospital
  • Nomura Keiko
    Department of Pediatrics, Kumamoto University Hospital
  • Kimura Shigemi
    Department of Pediatrics, Kumamoto University Hospital
  • Takahashi Yukitoshi
    Department of Pediatrics, National Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders

Bibliographic Information

Other Title
  • めまいで発症し亜急性に四肢の筋力低下・歩行障害が進行した橋本脳症の1男児例

Search this article

Abstract

  Hashimoto’s encephalopathy is an anti-thyroid antibody-positive autoimmune encephalopathy. We herein report the case of a 13-year-old male patient with subacute vertigo, muscle weakness in the extremities and gait disturbance who was diagnosed with Hashimoto’s encephalopathy. He showed no severe impairment of consciousness and no seizures, and there were no abnormalities on the brain MRI. However, epileptic spike and wave complexes were observed on an electroencephalogram, and a decline in blood flow was diffusely observed on brain SPECT (single photon emission computed tomography). His thyroid function was normal, but he was positive for anti-thyroid antibodies, such as anti-TPO (thyroid peroxidase) antibodies. He was also positive for serum anti-NAE (NH2-terminal alpha-enolase) antibodies. Systemic corticosteroid therapy and high-dose intravenous immunoglobulin therapy were effective, greatly improving his quality of life.

Journal

  • NO TO HATTATSU

    NO TO HATTATSU 48 (1), 45-47, 2016

    The Japanese Society of Child Neurology

Related Projects

See more

Details 詳細情報について

Report a problem

Back to top